Fortive Corp (FTV) Stock Analysis and Metrics

Fortive

NYSE: FTV

$61.27 ▼ -1.28 (-2.05%)

At close: Jul 8, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap19.14 Bn

P/E-1,495.03

P/S4.52

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)3.49 Bn

Revenue Growth (1y) (Qtr)7.68

Add ratio to table…

About

Fortive Corporation innovates essential technologies to keep the world safe and productive. The company designs, develops, manufactures, and markets products, software, and services across industrial and healthcare sectors. Headquartered in Everett, Washington, Fortive employs over 10,000 professionals in approximately 50 countries worldwide.

Fortive generates revenue through the sale of instrumentation, software, and services that support mission-critical workflows for industrial and healthcare customers. Its offerings include professional tools for maintenance and measurement, facility management software, connected safety systems, instrument sterilization solutions, biomedical test equipment, and clinical productivity platforms. These products and services are sold to a broad base of industrial operators, healthcare providers, and technical professionals seeking to enhance safety, efficiency, and compliance.

The company operates through the following segments: Intelligent Operating Solutions and Advanced Healthcare Solutions.

• Intelligent Operating Solutions: This segment provides advanced instrumentation, software, and services to tens of thousands of customers enabling mission-critical workflows in manufacturing, process industries, healthcare, utilities, power, communications, and electronics. Its products support maintenance, repair, measurement, condition monitoring, facility and asset lifecycle management, and connected worker safety and compliance. The segment markets its offerings under leading brands including FLUKE, SERVICECHANNEL, GORDIAN, ACCRUENT, INDUSTRIAL SCIENTIFIC, and INTELEX.

• Advanced Healthcare Solutions: This segment supplies critical workflow solutions that enable healthcare providers to deliver exceptional patient care more efficiently. Its offerings include instrument sterilization systems, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software. These solutions help ensure safety standards are met, operating rooms perform at peak efficiency, and complex procedures are followed accurately. The segment markets its products under brands such as ADVANCED STERILIZATION PRODUCTS “ASP”, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION.

Fortive holds leadership positions in many of the markets it serves, supported by strong brand recognition, innovative technologies, and deep applications expertise. The company faces competition from larger diversified corporations and specialized regional players, particularly in niches where low-cost entrants are increasing. Its competitive advantages stem from a broad portfolio, strong distribution channels, service capabilities, and a culture of continuous improvement driven by the Fortive Business System.

Fortive serves tens of thousands of customers across industrial and healthcare sectors, including electrical engineers, electricians, technicians, EHS professionals, facility managers, first responders, maintenance professionals, biomedical engineers, healthcare technicians, and hospital staff. Specific customer names are not disclosed in the filing, but the company serves a diverse base of end users in manufacturing, utilities, healthcare facilities, and communications infrastructure worldwide.

Investment Thesis

▲ Bull case

Fortive's execution of the Fortive Accelerator strategy is delivering tangible, sustainable growth that the market is underestimating, particularly through the acceleration of higher-margin, recurring revenue streams. The company reported double-digit adjusted EPS growth of over 25% in Q1, driven by operating leverage and structural cost savings, while core revenue growth of just over 5% was bolstered by strong performance in its software and services businesses. Notably, recurring revenue again grew faster than consolidated revenue in both segments, with Fluke achieving double-digit services growth and Industrial Scientific seeing strong gains in its hardware-as-a-service offering. This shift toward recurring revenue enhances revenue durability and predictability, reducing reliance on volatile capital expenditure cycles. Management highlighted that innovation velocity—particularly AI-enhanced product launches like Provation Mirror Documentation Assist in healthcare and CertiFiber Max in data centers—is creating meaningful pull-through opportunities across product suites, deepening customer engagement and expanding addressable markets. These initiatives are not yet fully reflected in current guidance but represent a structural shift toward higher-value, sticky revenue that could drive multi-year outperformance if execution continues at pace.
The company's disciplined capital allocation, particularly its aggressive share repurchase program, is creating significant shareholder value that is not being fully priced into the stock. Fortive has reduced its share count by just over 10% since the New Fortive spin-off in July 2025, deploying approximately $1.8 billion to repurchase 35 million shares. In Q1 alone, it completed roughly $500 million in buybacks, directly boosting adjusted EPS growth through reduced share count—a tailwind that contributed to the over 25% year-over-year increase in adjusted EPS. With the Board recently authorizing an additional 20 million shares available for repurchase under the general program, and $66.7 million remaining under the special purpose program tied to Ralliant dividends, Fortive has substantial dry powder to continue this capital return strategy. This approach leverages the company's strong free cash flow generation—trailing twelve-month conversion remains north of 100%—and reflects management's confidence in intrinsic value. The market may be overlooking how this combination of buybacks and operational execution compounds returns over time, especially as the company reinvests productivity gains into growth initiatives that fuel further cash generation.
Fluke's position in the data center ecosystem represents a hidden, multi-year growth catalyst that is underappreciated in current forecasts. While management discussed the CertiFiber Max launch and its strong customer response, they did not fully quantify the pull-through effect into adjacent product lines like power quality, battery testing, imaging, and calibration solutions—critical for both data center build-out and ongoing operations. The data center opportunity extends beyond initial construction into a durable, recurring demand for maintenance, monitoring, and optimization tools, where Fluke's brand strength and broad portfolio create a natural advantage. Fluke's commercial investments in high-growth verticals such as data centers, defense, and distributed energy are already showing early traction, and the business is positioned to benefit from secular trends like AI-driven infrastructure expansion and optical switching adoption. Given that Fluke comprises nearly 40% of Fortive's operations, even modest acceleration in this segment could meaningfully lift consolidated growth rates, particularly as the company gains specification into hyperscaler maintenance tool sets—an enduring competitive moat that could drive premium pricing and share gains over the long term.

Fortive's execution of the Fortive Accelerator strategy is delivering tangible, sustainable growth that the market is underestimating, particularly through the acceleration of higher-margin, recurring revenue streams. The company reported double-digit adjusted EPS growth of over 25% in Q1, driven by operating leverage and structural cost savings, while core revenue growth of just over 5% was bolstered by strong performance in its software and services businesses. Notably, recurring revenue again grew faster than consolidated revenue in both segments, with Fluke achieving double-digit services growth and Industrial Scientific seeing strong gains in its hardware-as-a-service offering. This shift toward recurring revenue enhances revenue durability and predictability, reducing reliance on volatile capital expenditure cycles. Management highlighted that innovation velocity—particularly AI-enhanced product launches like Provation Mirror Documentation Assist in healthcare and CertiFiber Max in data centers—is creating meaningful pull-through opportunities across product suites, deepening customer engagement and expanding addressable markets. These initiatives are not yet fully reflected in current guidance but represent a structural shift toward higher-value, sticky revenue that could drive multi-year outperformance if execution continues at pace.
The company's disciplined capital allocation, particularly its aggressive share repurchase program, is creating significant shareholder value that is not being fully priced into the stock. Fortive has reduced its share count by just over 10% since the New Fortive spin-off in July 2025, deploying approximately $1.8 billion to repurchase 35 million shares. In Q1 alone, it completed roughly $500 million in buybacks, directly boosting adjusted EPS growth through reduced share count—a tailwind that contributed to the over 25% year-over-year increase in adjusted EPS. With the Board recently authorizing an additional 20 million shares available for repurchase under the general program, and $66.7 million remaining under the special purpose program tied to Ralliant dividends, Fortive has substantial dry powder to continue this capital return strategy. This approach leverages the company's strong free cash flow generation—trailing twelve-month conversion remains north of 100%—and reflects management's confidence in intrinsic value. The market may be overlooking how this combination of buybacks and operational execution compounds returns over time, especially as the company reinvests productivity gains into growth initiatives that fuel further cash generation.
Fluke's position in the data center ecosystem represents a hidden, multi-year growth catalyst that is underappreciated in current forecasts. While management discussed the CertiFiber Max launch and its strong customer response, they did not fully quantify the pull-through effect into adjacent product lines like power quality, battery testing, imaging, and calibration solutions—critical for both data center build-out and ongoing operations. The data center opportunity extends beyond initial construction into a durable, recurring demand for maintenance, monitoring, and optimization tools, where Fluke's brand strength and broad portfolio create a natural advantage. Fluke's commercial investments in high-growth verticals such as data centers, defense, and distributed energy are already showing early traction, and the business is positioned to benefit from secular trends like AI-driven infrastructure expansion and optical switching adoption. Given that Fluke comprises nearly 40% of Fortive's operations, even modest acceleration in this segment could meaningfully lift consolidated growth rates, particularly as the company gains specification into hyperscaler maintenance tool sets—an enduring competitive moat that could drive premium pricing and share gains over the long term.

▼ Bear case

Fortive's margin expansion is increasingly dependent on transient tailwinds and cost-cutting measures that may not be sustainable, posing a risk to long-term profitability that the market is overlooking. While adjusted EBITDA margin expanded 140 basis points year-over-year in Q1 to just over 29%, this was driven by operating leverage from the 150 basis point selling days tailwind, foreign exchange benefits, and structural cost savings—factors that are either reversing or non-recurring. The company acknowledged that tariffs imposed last year continue to pressure gross margins, with adjusted gross margin down about 100 basis points consolidated and 150 basis points in IOS, and while they claim to be "countermeasured" from a bottom-line perspective via pricing and cost actions, these measures may erode over time as competitors adjust or input costs persist. Furthermore, management noted that the benefits of prior-year cost actions will lap in the back half of 2026, leading to less margin expansion in Q3 and Q4 compared to the first half. With core revenue growth guidance of only 2% to 3% for the full year and the expectation that Q2 and Q3 adjusted EPS will be broadly similar to Q1's $0.70, there is limited room for error if growth disappoints or cost inflation reaccelerates, potentially forcing a choice between margin defense and growth investment.
The company's growth initiatives, particularly in AI and software, may be overstated in their near-term impact and face significant execution risks that are not being adequately discounted by the market. While Fortive highlighted AI-powered products like Provation Mirror Documentation Assist and ServiceChannel AI as drivers of innovation velocity, the actual revenue contribution from these offerings remains unclear and likely immaterial relative to the overall business. The healthcare software segment, though growing, operates in a market where hospital capital expenditure remains under pressure due to reimbursement policies and budget constraints, limiting the scalability of even well-executed solutions. Similarly, in FAL, while ServiceChannel showed strength, the broader Facilities and Asset Lifecycle Solutions segment relies on government spending cycles—such as Gordian's June year-end exposure—which are inherently lumpy and subject to political and fiscal uncertainty. Management admitted they did not presume extra-normal spend in Q2 guidance for Gordian, indicating a lack of visibility into whether historical patterns will return. This reliance on episodic demand, combined with the long sales cycles typical of software and infrastructure-related sales, creates execution risk that could delay or diminish the expected returns on innovation and commercial investments.
Fortive's balance sheet, while currently strong, carries latent risks from rising debt levels and refinancing needs that could constrain flexibility if market conditions deteriorate, a factor the market may be underestimating. The company recently issued $600 million of 2031 notes and $500 million of 2036 notes to refinance impending debt, including the repayment of its 3.150% Senior Notes due June 15, 2026. This increased long-term debt to $2.589 billion as of Q1-end, pushing gross debt to adjusted EBITDA to 2.8 times—up from prior levels and approaching the upper end of what many industrial peers consider manageable. While management emphasized ample capacity for capital deployment, the increased interest expense—guided to just over $135 million for the full year—represents a fixed obligation that must be met regardless of operating performance. If economic headwinds intensify, such as a slowdown in key end markets like data centers or healthcare, or if tariff-related disruptions persist, the company could face pressure to prioritize debt service over share repurchases or growth investments. This financial leverage reduces the margin for error and could limit Fortive's ability to pursue accretive M&A or weather prolonged downturns, especially given its history of using debt to fund shareholder returns post-separation.

Fortive's margin expansion is increasingly dependent on transient tailwinds and cost-cutting measures that may not be sustainable, posing a risk to long-term profitability that the market is overlooking. While adjusted EBITDA margin expanded 140 basis points year-over-year in Q1 to just over 29%, this was driven by operating leverage from the 150 basis point selling days tailwind, foreign exchange benefits, and structural cost savings—factors that are either reversing or non-recurring. The company acknowledged that tariffs imposed last year continue to pressure gross margins, with adjusted gross margin down about 100 basis points consolidated and 150 basis points in IOS, and while they claim to be "countermeasured" from a bottom-line perspective via pricing and cost actions, these measures may erode over time as competitors adjust or input costs persist. Furthermore, management noted that the benefits of prior-year cost actions will lap in the back half of 2026, leading to less margin expansion in Q3 and Q4 compared to the first half. With core revenue growth guidance of only 2% to 3% for the full year and the expectation that Q2 and Q3 adjusted EPS will be broadly similar to Q1's $0.70, there is limited room for error if growth disappoints or cost inflation reaccelerates, potentially forcing a choice between margin defense and growth investment.
The company's growth initiatives, particularly in AI and software, may be overstated in their near-term impact and face significant execution risks that are not being adequately discounted by the market. While Fortive highlighted AI-powered products like Provation Mirror Documentation Assist and ServiceChannel AI as drivers of innovation velocity, the actual revenue contribution from these offerings remains unclear and likely immaterial relative to the overall business. The healthcare software segment, though growing, operates in a market where hospital capital expenditure remains under pressure due to reimbursement policies and budget constraints, limiting the scalability of even well-executed solutions. Similarly, in FAL, while ServiceChannel showed strength, the broader Facilities and Asset Lifecycle Solutions segment relies on government spending cycles—such as Gordian's June year-end exposure—which are inherently lumpy and subject to political and fiscal uncertainty. Management admitted they did not presume extra-normal spend in Q2 guidance for Gordian, indicating a lack of visibility into whether historical patterns will return. This reliance on episodic demand, combined with the long sales cycles typical of software and infrastructure-related sales, creates execution risk that could delay or diminish the expected returns on innovation and commercial investments.
Fortive's balance sheet, while currently strong, carries latent risks from rising debt levels and refinancing needs that could constrain flexibility if market conditions deteriorate, a factor the market may be underestimating. The company recently issued $600 million of 2031 notes and $500 million of 2036 notes to refinance impending debt, including the repayment of its 3.150% Senior Notes due June 15, 2026. This increased long-term debt to $2.589 billion as of Q1-end, pushing gross debt to adjusted EBITDA to 2.8 times—up from prior levels and approaching the upper end of what many industrial peers consider manageable. While management emphasized ample capacity for capital deployment, the increased interest expense—guided to just over $135 million for the full year—represents a fixed obligation that must be met regardless of operating performance. If economic headwinds intensify, such as a slowdown in key end markets like data centers or healthcare, or if tariff-related disruptions persist, the company could face pressure to prioritize debt service over share repurchases or growth investments. This financial leverage reduces the margin for error and could limit Fortive's ability to pursue accretive M&A or weather prolonged downturns, especially given its history of using debt to fund shareholder returns post-separation.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Scientific & Technical Instruments

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	COHR	Coherent Corp.	3,591.32 Bn	8,242.43	543.97	3.19 Bn
2	NOVT	Novanta Inc	69.39 Bn	1,291.61	69.04	0.24 Bn
3	KEYS	Keysight Technologies, Inc.	57.75 Bn	58.86	10.17	2.53 Bn
4	TDY	Teledyne Technologies Inc	30.63 Bn	32.80	4.92	2.48 Bn
5	FTV	Fortive Corp	19.14 Bn	-1,495.03	4.52	3.49 Bn
6	TRMB	Trimble Inc.	12.33 Bn	27.03	3.34	1.41 Bn
7	CGNX	Cognex Corp	11.87 Bn	83.30	11.34	-
8	ST	Sensata Technologies Holding plc	6.78 Bn	139.80	1.82	2.83 Bn

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password